PITTSBURGH--(BUSINESS WIRE)--RQM+, a global leader in MedTech services, today announced the appointment of Eric Pauls as chief customer officer, a newly-created senior executive role. With a focus on customer experience and satisfaction, Pauls will steer the company’s global commercialization team, ensuring an alignment between organizational objectives and customer needs.
"I'm thrilled to join the RQM+ team and to focus on creating growing value for our customers," said Pauls. "I’m confident that with a dedicated team and a customer-centric approach, we will continue to lead in the MedTech services industry."
Based in Pittsburgh, Pauls brings more than two decades of executive sales and business development experience to help drive and support current and future growth. In his most recent role, he excelled as a senior sales executive at Tactile Medical, where he was directly responsible for the P&L management, business development, portfolio expansion and annual operating plan. Pauls is renowned for his ability to serve as a trusted advisor to key customers, peers and his team, aligning perfectly with the values and goals of RQM+. In his previous role as an executive sales leader of Philips, he was accountable for driving the annual operating plan, business development, sales excellence and operational compliance.
As a MedTech veteran, Pauls' deep-rooted understanding of customer challenges is unparalleled, drawing from a career that started as a respiratory therapist in hospitals and sleep disorder centers. This unique perspective and extensive experience in the industry add an invaluable layer of insight, allowing him to address the specific needs and pain points of customers in our complex MedTech ecosystem.
"We are incredibly excited to welcome Eric as our new chief customer officer,” said CEO Margaret Keegan. “His commitment to building meaningful relationships and delivering tangible results is in complete harmony with our company values and goals. Eric brings decades of understanding of our customers and with him on board, we are more confident than ever in our ability to navigate the complexities of the MedTech industry and deliver unmatched value to our customers and stakeholders."
Pauls’ appointment signifies a monumental step for RQM+ in continuing to be a global leader in MedTech services. His strategic vision, leadership qualities and depth of experience make him an invaluable addition to the RQM+ team.
RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+’s global team of clinical, technical, and top industry experts push the boundaries of excellence. With more former FDA, Medicines, and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. We reduce commercialization risk by offering a full complement of CRO services to progress medical devices, digital therapeutics and diagnostics onto the market and keep them there. In addition to early- and mid-stage MedTech companies, we currently work with 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies. For more information, visit RQMplus.com.